mofezolac has been researched along with Angiogenesis, Pathologic in 1 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshida, S | 1 |
| Amano, H | 1 |
| Hayashi, I | 1 |
| Kitasato, H | 1 |
| Kamata, M | 1 |
| Inukai, M | 1 |
| Yoshimura, H | 1 |
| Majima, M | 1 |
1 other study available for mofezolac and Angiogenesis, Pathologic
| Article | Year |
|---|---|
COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo.
Topics: Animals; Antibodies, Blocking; Aspirin; Benzenesulfonates; Carcinoma, Lewis Lung; Cyclooxygenase Inh | 2003 |